daniel drucker glp 1 Q&A with Drucker: Med URSA × IMMSA × UPSA

Ozempic is the word on everyone's lips, and research reveals that the market for weight management supplements is worth over five billion USD, with analysts predicting a 14% uptick in the next ten years

And for those who actively struggle with an eating disorder, GLP-1s may offer an appealing shortcut to dangerous goals

Therefore, current treatment guidelines recommend maintenance of an optimal weight and stringent management of lipid levels in addition to glycemic control [3]

This is because a lot of private insurers use Medicare guidelines as a base when determining which treatments theyll cover

"Comparative Analysis of GLP-1 Receptor Agonists in Weight Management." International Journal of Obesity Research, 2023